More frequently, metabolic alterations in cancer are consequent to the subversion of major oncogenic and/or tumor suppressor pathways, including RAS, p53, MYC, PI3K, and mTOR, which can profoundly alter energy production, biomass synthesis, and redox control. The gene discussed is TP53; the disease is neoplasm.